Follow The Filings

TVRD Tvardi Therapeutics

Tvardi Therapeutics earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.69 —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 7.01,9.01
424B5
8-K 8.01,9.01
8-K 7.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
424B3
8-K 2.02,9.01
10-K
8-K 8.01
424B3
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 5.02
8-K 7.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
424B3
S-1/A

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Jun 9, 2026 (5 forms)

8 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.